Effects of low-dose furosemide combined with aminophylline on the renal function in septic shock patients

References

• Rachoin J, Weisberg L. Renal replacement therapy in the ICU. Crit Care Med. 2019;47(5):715–721.
   PubMed Web of Science ®Google Scholar
• Zuk A, Bonventre J. Recent advances in acute kidney injury and its consequences and impact on chronic kidney disease. Curr Opin Nephrol Hypertens. 2019;28(4):397–405.
   PubMed Web of Science ®Google Scholar
• Montomoli J, Donati A, Ince C. Acute kidney injury and fluid resuscitation in septic patients: are we protecting the kidney? Nephron. 2019;143(3):170–173.
   PubMed Web of Science ®Google Scholar
• Griffin B, Liu K, Teixeira J. Critical care nephrology: core curriculum 2020. Am J Kidney Dis. 2020;75(3):435–452.
   PubMed Web of Science ®Google Scholar
• Andrikos E, Tseke P, Balafa O, et al. Epidemiology of acute renal failure in ICUs: a multi-center prospective study. Blood Purif. 2009;28(3):239–244.
   PubMedGoogle Scholar
• Bellomo R, Kellum J, Ronco C, et al. Acute kidney injury in sepsis. Intensive Care Med. 2017;43(6):816–828.
   PubMed Web of Science ®Google Scholar
• Ostermann M, Chang R. Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med. 2007;35(8):1837–1843.
   PubMed Web of Science ®Google Scholar
• Schrier R, Wang W. Acute renal failure and sepsis. N Engl J Med. 2004;351(2):159–169.
   PubMed Web of Science ®Google Scholar
• Bagshaw S, George C, Bellomo R, the ANZICS Database Management Committee Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care. 2008;12(2):R47.
   PubMed Web of Science ®Google Scholar
• Swärd K, Valsson F, Sellgren J, et al. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans. Intensive Care Med. 2005;31(1):79–85.
   PubMed Web of Science ®Google Scholar
• Torrente A, Miller P, Cronin R, et al. Effects of furosemide and acetylcholine in norepinephrine-induced acute renal failure. Am J Physiol. 1978;235(2):F131–136.
   PubMedGoogle Scholar
• Kramer H, Schuüürmann J, Wassermann C, et al. Prostaglandin-independent protection by furosemide from oliguric ischemic renal failure in conscious rats. Kidney Int. 1980;17(4):455–464.
   PubMed Web of Science ®Google Scholar
• Redfors , Bengt Bragadottir. Acute renal failure is NOT an "acute renal success"—a clinical study on the renal oxygen supply/demand relationship in acute kidney injury. Crit Care Med. 2010;38(8):1695–1701.
   PubMed Web of Science ®Google Scholar
• Dai B, Liu Y, Fu L, et al. Effect of theophylline on prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials. Am J Kidney Dis. 2012;60(3):360–370.
   PubMed Web of Science ®Google Scholar
• Bagshaw SM, Ghali WA. Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Arch Intern Med. 2005;165(10):1087–1093.
   PubMedGoogle Scholar
• Hall JE, Granger JP, Hester RL. Interactions between adenosine and angiotensin II in controlling glomerular filtration. Am J Physiol. 1985;248(3 Pt 2):F340–346.
   PubMedGoogle Scholar
• Hansen PB, Schnermann J. Vasoconstrictor and vasodilator effects of adenosine in the kidney. Am J Physiol Renal Physiol. 2003;285(4):F590–599.
   PubMed Web of Science ®Google Scholar
• Ho K, Power B. Benefits and risks of furosemide in acute kidney injury. Anaesthesia. 2010;65(3):283–293.
   PubMed Web of Science ®Google Scholar
• Rhodes A, Evans L, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock:2016. Crit Care Med. 2017;45(3):486–552.
   PubMed Web of Science ®Google Scholar
• Mehta RL. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA. 2002;288(20):2547–2553.
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138.
   Web of Science ®Google Scholar
• Zhao G, Xu C, Ying J, et al. Association between furosemide administration and outcomes in critically ill patients with acute kidney injury. Crit Care. 2020;24(1):75.
   PubMed Web of Science ®Google Scholar
• Cruz DN, Antonelli M, Fumagalli R, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA. 2009;301(23):2445–2452.
   PubMed Web of Science ®Google Scholar
• Hernández G, Ospina-Tascón GA, Damiani LP, for the ANDROMEDA-SHOCK Investigators and the Latin America Intensive Care Network (LIVEN), et al. Effect of a resuscitation strategy targeting peripheral perfusion status vsserum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial. JAMA. 2019;321(7):654–664.
   PubMed Web of Science ®Google Scholar
• Vaara S, Korhonen A, Kaukonen K, The FINNAKI Study Group, et al. Fluid overload is associated with an increased risk for 90-day mortality in critically ill patients with renal replacement therapy: data from the prospective FINNAKI study. Crit Care. 2012;16(5):R197.
   PubMed Web of Science ®Google Scholar
• Vaara S, Ostermann M, Bitker L, on behalf of the REVERSE-AKI Study Team, et al. Restrictive fluid management versus usual care in acute kidney injury (REVERSE-AKI): a pilot randomized controlled feasibility trial. Intensive Care Med. 2021;47(6):665–673.
   PubMed Web of Science ®Google Scholar
• Semler MW, Self WH, Wanderer JP, et al. Balanced crystalloids versus saline in critically ill adults. N Engl J Med. 2018;378(9):829–839.
   PubMed Web of Science ®Google Scholar
• Commereuc M, Nevoret C, Radermacher P, et al. Hyperchloremia is not associated with AKI or death in septic shock patients: results of a post hoc analysis of the "HYPER2S" trial. Ann Intensive Care. 2019;9(1):95.
   PubMed Web of Science ®Google Scholar